Todays Report: Today: Compass Capital Management Inc. Raises it position for CVS Health Corporation (CVS)

Today: Compass Capital Management Inc. Raises it position for CVS Health Corporation (CVS)

Compass Capital Management Inc. raised its stake in CVS Health Corporation (NYSE:CVS) by 5.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 208,052 shares of the pharmacy operator’s stock after buying an additional 10,077 shares during the period. CVS Health Corporation comprises about 3.8% of Compass Capital Management Inc.’s investment portfolio, making the stock its 15th largest position. Compass Capital Management Inc.’s holdings in CVS Health Corporation were worth $19,919,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. MU Investments Co. Ltd. increased its position in CVS Health Corporation by 62.0% in the second quarter. MU Investments Co. Ltd. now owns 1,150 shares of the pharmacy operator’s stock valued at $109,000 after buying an additional 440 shares in the last quarter. Springbok Capital Management LLC increased its position in CVS Health Corporation by 190.5% in the first quarter. Springbok Capital Management LLC now owns 1,130 shares of the pharmacy operator’s stock valued at $117,000 after buying an additional 741 shares in the last quarter. Arcadia Investment Management Corp MI increased its position in CVS Health Corporation by 87.7% in the second quarter. Arcadia Investment Management Corp MI now owns 1,605 shares of the pharmacy operator’s stock valued at $154,000 after buying an additional 750 shares in the last quarter. Physicians Financial Services Inc. increased its position in CVS Health Corporation by 5.8% in the second quarter. Physicians Financial Services Inc. now owns 1,849 shares of the pharmacy operator’s stock valued at $177,000 after buying an additional 101 shares in the last quarter. Finally, Highland Private Wealth Management purchased a new position in CVS Health Corporation during the first quarter valued at about $198,000. 80.95% of the stock is currently owned by institutional investors and hedge funds.

Shares of CVS Health Corporation (NYSE:CVS) traded up 0.91% during midday trading on Friday, reaching $88.80. 6,705,822 shares of the company traded hands. The firm has a market capitalization of $94.68 billion, a PE ratio of 20.43 and a beta of 0.83. The company has a 50-day moving average of $90.11 and a 200 day moving average of $96.45. CVS Health Corporation has a 12-month low of $85.41 and a 12-month high of $106.67.

CVS Health Corporation (NYSE:CVS) last announced its quarterly earnings data on Tuesday, August 2nd. The pharmacy operator reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.30 by $0.02. CVS Health Corporation had a net margin of 2.88% and a return on equity of 15.86%. The firm had revenue of $43.70 billion for the quarter, compared to analyst estimates of $44.28 billion. During the same quarter in the prior year, the business earned $1.19 earnings per share. The business’s quarterly revenue was up 17.6% compared to the same quarter last year. On average, equities analysts forecast that CVS Health Corporation will post $5.86 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 3rd. Stockholders of record on Monday, October 24th will be issued a dividend of $0.425 per share. The ex-dividend date of this dividend is Thursday, October 20th. This represents a $1.70 annualized dividend and a dividend yield of 1.91%. CVS Health Corporation’s dividend payout ratio is currently 39.08%.

Several research analysts have issued reports on the company. Vetr raised CVS Health Corporation from a “hold” rating to a “buy” rating and set a $94.49 price objective on the stock in a report on Monday, October 10th. Credit Suisse Group AG reaffirmed an “outperform” rating and set a $110.00 price objective (down previously from $115.00) on shares of CVS Health Corporation in a report on Tuesday, October 4th. Robert W. Baird reduced their price objective on CVS Health Corporation from $114.00 to $104.00 and set an “outperform” rating on the stock in a report on Monday, October 3rd. Leerink Swann reaffirmed an “outperform” rating and set a $105.00 price objective (down previously from $110.00) on shares of CVS Health Corporation in a report on Sunday, October 2nd. Finally, Mizuho reaffirmed a “buy” rating and set a $111.00 price objective on shares of CVS Health Corporation in a report on Friday, September 30th. Five research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has assigned a strong buy rating to the company. CVS Health Corporation presently has a consensus rating of “Buy” and an average price target of $112.40.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail/LTC and Corporate. The Company offers a range of products and services, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare.

Related posts

Leave a Comment